1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Biopsy Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 CTC Detection
1.2.3 ctDNA Detection
1.2.4 Exosome Detection
1.3 Market by Application
1.3.1 Global Liquid Biopsy Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Liquid Biopsy Services Market Perspective (2017-2028)
2.2 Liquid Biopsy Services Growth Trends by Region
2.2.1 Liquid Biopsy Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Liquid Biopsy Services Historic Market Size by Region (2017-2022)
2.2.3 Liquid Biopsy Services Forecasted Market Size by Region (2023-2028)
2.3 Liquid Biopsy Services Market Dynamics
2.3.1 Liquid Biopsy Services Industry Trends
2.3.2 Liquid Biopsy Services Market Drivers
2.3.3 Liquid Biopsy Services Market Challenges
2.3.4 Liquid Biopsy Services Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Liquid Biopsy Services Players by Revenue
3.1.1 Global Top Liquid Biopsy Services Players by Revenue (2017-2022)
3.1.2 Global Liquid Biopsy Services Revenue Market Share by Players (2017-2022)
3.2 Global Liquid Biopsy Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Biopsy Services Revenue
3.4 Global Liquid Biopsy Services Market Concentration Ratio
3.4.1 Global Liquid Biopsy Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy Services Revenue in 2021
3.5 Liquid Biopsy Services Key Players Head office and Area Served
3.6 Key Players Liquid Biopsy Services Product Solution and Service
3.7 Date of Enter into Liquid Biopsy Services Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Liquid Biopsy Services Breakdown Data by Type
4.1 Global Liquid Biopsy Services Historic Market Size by Type (2017-2022)
4.2 Global Liquid Biopsy Services Forecasted Market Size by Type (2023-2028) 5 Liquid Biopsy Services Breakdown Data by Application
5.1 Global Liquid Biopsy Services Historic Market Size by Application (2017-2022)
5.2 Global Liquid Biopsy Services Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Liquid Biopsy Services Market Size (2017-2028)
6.2 North America Liquid Biopsy Services Market Size by Country (2017-2022)
6.3 North America Liquid Biopsy Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Liquid Biopsy Services Market Size (2017-2028)
7.2 Europe Liquid Biopsy Services Market Size by Country (2017-2022)
7.3 Europe Liquid Biopsy Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Services Market Size (2017-2028)
8.2 Asia-Pacific Liquid Biopsy Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Liquid Biopsy Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Liquid Biopsy Services Market Size (2017-2028)
9.2 Latin America Liquid Biopsy Services Market Size by Country (2017-2022)
9.3 Latin America Liquid Biopsy Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Services Market Size (2017-2028)
10.2 Middle East & Africa Liquid Biopsy Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Liquid Biopsy Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Detail
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Liquid Biopsy Services Introduction
11.1.4 Bio-Rad Revenue in Liquid Biopsy Services Business (2017-2022)
11.1.5 Bio-Rad Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Liquid Biopsy Services Introduction
11.2.4 Roche Revenue in Liquid Biopsy Services Business (2017-2022)
11.2.5 Roche Recent Development
11.3 Biocartis
11.3.1 Biocartis Company Detail
11.3.2 Biocartis Business Overview
11.3.3 Biocartis Liquid Biopsy Services Introduction
11.3.4 Biocartis Revenue in Liquid Biopsy Services Business (2017-2022)
11.3.5 Biocartis Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Liquid Biopsy Services Introduction
11.4.4 Qiagen Revenue in Liquid Biopsy Services Business (2017-2022)
11.4.5 Qiagen Recent Development
11.5 Guardant Health
11.5.1 Guardant Health Company Detail
11.5.2 Guardant Health Business Overview
11.5.3 Guardant Health Liquid Biopsy Services Introduction
11.5.4 Guardant Health Revenue in Liquid Biopsy Services Business (2017-2022)
11.5.5 Guardant Health Recent Development
11.6 MDxHealth
11.6.1 MDxHealth Company Detail
11.6.2 MDxHealth Business Overview
11.6.3 MDxHealth Liquid Biopsy Services Introduction
11.6.4 MDxHealth Revenue in Liquid Biopsy Services Business (2017-2022)
11.6.5 MDxHealth Recent Development
11.7 OME Care
11.7.1 OME Care Company Detail
11.7.2 OME Care Business Overview
11.7.3 OME Care Liquid Biopsy Services Introduction
11.7.4 OME Care Revenue in Liquid Biopsy Services Business (2017-2022)
11.7.5 OME Care Recent Development
11.8 NeoGenomics Laboraories
11.8.1 NeoGenomics Laboraories Company Detail
11.8.2 NeoGenomics Laboraories Business Overview
11.8.3 NeoGenomics Laboraories Liquid Biopsy Services Introduction
11.8.4 NeoGenomics Laboraories Revenue in Liquid Biopsy Services Business (2017-2022)
11.8.5 NeoGenomics Laboraories Recent Development
11.9 Sysmex Inostics
11.9.1 Sysmex Inostics Company Detail
11.9.2 Sysmex Inostics Business Overview
11.9.3 Sysmex Inostics Liquid Biopsy Services Introduction
11.9.4 Sysmex Inostics Revenue in Liquid Biopsy Services Business (2017-2022)
11.9.5 Sysmex Inostics Recent Development
11.10 Menarini Silicon Biosystems
11.10.1 Menarini Silicon Biosystems Company Detail
11.10.2 Menarini Silicon Biosystems Business Overview
11.10.3 Menarini Silicon Biosystems Liquid Biopsy Services Introduction
11.10.4 Menarini Silicon Biosystems Revenue in Liquid Biopsy Services Business (2017-2022)
11.10.5 Menarini Silicon Biosystems Recent Development
11.11 Adaptive Biotechnologies
11.11.1 Adaptive Biotechnologies Company Detail
11.11.2 Adaptive Biotechnologies Business Overview
11.11.3 Adaptive Biotechnologies Liquid Biopsy Services Introduction
11.11.4 Adaptive Biotechnologies Revenue in Liquid Biopsy Services Business (2017-2022)
11.11.5 Adaptive Biotechnologies Recent Development
11.12 Biocept
11.12.1 Biocept Company Detail
11.12.2 Biocept Business Overview
11.12.3 Biocept Liquid Biopsy Services Introduction
11.12.4 Biocept Revenue in Liquid Biopsy Services Business (2017-2022)
11.12.5 Biocept Recent Development
11.13 Angle plc
11.13.1 Angle plc Company Detail
11.13.2 Angle plc Business Overview
11.13.3 Angle plc Liquid Biopsy Services Introduction
11.13.4 Angle plc Revenue in Liquid Biopsy Services Business (2017-2022)
11.13.5 Angle plc Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
